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Abstract
Numerous strategies that are currently used to regenerate bone depend on employing biocompatible materials exhibiting a
scaffold structure. These scaffolds can be manufactured containing particular active compounds, such as hydroxyapatite
precursors and/or different growth factors to enhance bone regeneration process. Herein, we have immobilized calcium
phosphate salts (CPS) and bone morphogenetic protein 2 (BMP-2) – combined or alone – into chitosan scaffolds using ISISA
process. We have analyzed whether the immobilized bone morphogenetic protein preserved its osteoinductive capability
after manufacturing process as well as BMP-2 in vitro release kinetic. We have also studied both the in vitro and in vivo
biocompatibility of the resulting scaffolds using a rabbit model. Results indicated that rhBMP-2 remained active in the
scaffolds after the manufacturing process and that its release kinetic was different depending on the presence of CPS. In
vitro and in vivo findings showed that cells grew more in scaffolds with both CPS and rhBMP-2 and that these scaffolds
induced more bone formation in rabbit tibia. Thus chitosan scaffolds containing both CPS and rhBMP-2 were more
osteoinductive than their counterparts alone indicating that could be useful for bone regeneration purposes, such as some
applications in dentistry.
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Introduction
One of the main topics in bone tissue engineering is the quest
for functional materials capable of promoting tissue regeneration.
Considering that bone is mostly composed of collagen and
hydroxyapatite (HAp), biomaterials containing chemical-ana-
logues and/or chemical-inducers of any of these compounds –
or, ideally, of both – have been widely explored in the field of bone
tissue engineering as they can eventually accelerate bone
regeneration [1]. Thus, a wide number of mineralized and
biomineralized scaffolds – with either HAp or other calcium
phosphate salts – have been proved to be more efficient for
regeneration purposes than the non-mineralized counterparts [2–
4]. Interestingly, the use of low and non-crystalline forms of
calcium phosphate salts (e.g. amorphous calcium phosphate, ACP)
have been the preferred choice because the mechanism for HAp
formation (i.e. based on dissolution and recrystallization) is
favoured in presence of low- and non-crystalline salts as compared
to more crystalline ones [5,6].
Besides HAp precursors, a group of growth factors known as
bone morphogenetic proteins (BMPs) has been extensively studied
for applications related to bone regeneration. Bone healing
processes involve a complex integration of cells, growth factors,
and the extracellular matrix, and it is widely accepted that
naturally occurring BMPs are critical players in these processes. In
particular, BMPs are expressed in the early stages of fracture
repair where it is likely that small amounts are released from the
extracellular matrix of the fractured bone. Tissue that first bridges
the fracture site is known as the fracture callus. Bone healing
continues upon replacement of fracture callus with lamellar bone –
typically in the form of trabecular bone – by a combination of
endochondral ossification and bone mineralization processes – in
charge of, respectively, cartilage and bone replacement. Healing
eventually terminates upon a remodelling process, where part of
the trabecular bone becomes compact bone and the excess of
trabecular bone is resorbed by osteoclasts. The current view of the
role of BMPs in described fracture repair process is that
these molecules are primarily activators of differentiation in
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osteoprogenitor and mesenchymal cells destined to become
osteoblasts and chrondrocytes which form woven bone and
cartilage [7].
Therefore BMPs are osteoinductive and have been shown to
increase bone formation in research studies [8–10]. Genetic
recombinant techniques have made possible the production of
recombinant human BMP-2 (rhBMP-2), the local administration
of which have also induced ectopic bone formation, improved the
healing of fractures and bone defects in animals and even
stimulated bone formation by human bone marrow-derived
stromal cells in vivo [11–14]. However, the rhBMP-2 performance
upon in vivo administration may be limited by its short biological
half-life and its rapid clearance after injection [15]. Hence,
incorporation of rhBMP-2 into some biomaterials may improve its
clinical therapeutic effectiveness. Moreover, rhBMP-2 release from
these biomaterials may allow maintaining an effective local
concentration, achieving prolonged availability, and preventing
the systematic risk of high dose [16,17].
Numerous strategies that are currently used to engineer tissues
depend on employing biocompatible and/or biodegradable
materials exhibiting a scaffold structure. On one hand, the
structural similarities of these scaffolds with synthetic extra cellular
matrix (ECM) are helpful for cell adhesion and serve to organize
cells into a three-dimensional architecture. Additionally, scaffolds
act as substrates where any of the above-mentioned compounds
that induce bone formation can be immobilized and subsequently
released. Herein, we describe the preparation of chitosan (CHI)
scaffolds containing rhBMP-2, either alone or besides calcium
phosphate salts (CPS). CHI is a cationic copolymer of N-
acetylglucosamine and glucosamine of natural origin widely used
in tissue engineering [18–22]. The preparation process consisted of
an enzymatically-induced gelation of CHI (based on the urease-
assisted hydrolysis of urea at room temperature) [23] followed by a
unidirectional freeze-drying process [24–26] (also called ice
segregation induced self-assembly, ISISA) [27,28] that allows the
formation of macroporous scaffolds with an excellent control of
the structural features and a homogeneous distribution of any
compound eventually immobilized within the scaffolding struc-
ture. We have recently described this process for the preparation
of CHI scaffolds containing ACP (both alone and in combination
with anhydrous ciprofloxacin crystals, a synthetic antimicrobial
fluoroquinolone) [29,30] but the immobilization of active rhBMP-
2 – rather than the simple post-synthetic adsorption onto the
scaffold [31] – requires some attention. In this case, the mild
processing shows promising conditions for the activity preservation
of the immobilized protein. With regard to the structural features
of the resulting materials, we have used scanning electron
microscopy (SEM) to study the morphology of the macroporous
scaffolds. The mechanical properties as well as the swelling of the
different scaffolds were also evaluated. With regard to the
functional features provided to the resulting materials, here we
have demonstrated that the intrinsic osteoinductive capability of
rhBMP-2 was preserved when immobilized within the scaffold
structure and we have also studied its kinetic release. We have
studied the in vitro biocompatibility of the resulting scaffolds.
Finally, we have created defects of 4 mm in diameter in rabbit
tibias and evaluated the in vivo osteoinductive response of the
scaffolds.
Materials and Methods
1. Ethics statement
All animal handling and experimental procedures were
approved by the Animal Care and Use Committee of Universidad
Complutense, according to the guidelines for ethical care of
experimental animals of the European Community.
2. Materials
Chitosan (CHI, Batch#06513AE, Av. Mol. Wt. 617 kDa,
deacetylation degree (DD) 8862), hydroxyapatite (HAp,
Batch#07424MD, reagent grade), urease (from Canavalia ensiformis
(Jack Bean) Type III, Sigma lot 115K7030, 45 units/mL) and urea
were from Sigma-Aldrich and used as received unless otherwise
indicated. rhBMP-2 (from Escherichia coli) was kindly supplied by
Noricum S.L. (Spain).
3. Samples Preparation
3.1. Urease-assisted preparation of hydrogels. Bare CHI
hydrogels were prepared as described elsewhere. Briefly, an
aqueous solution of CHI (1 g, 2.83 wt.% in acetic acid 0.15 M;
pH 4.5) was mixed with an aqueous solution of urea (0.125 mL,
urea 2 M, HCl 0.3 M; pH 3) under vigorous stirring in an ice-cold
bath. The resulting solution was mixed with 0.0875 mL of a
freshly prepared urease aqueous solution (45 units/mL) and stirred
for 15 min. The resulting translucent liquid mixture was loaded
into an insulin syringe (1 mL) and aged for gelation (24 hours at
37uC up to reach a pH of ca. 7.0).
Hydrogels containing rhBMP-2 were prepared following the
procedure described above for CHI hydrogels except for the
addition of an aqueous solution of rhBMP-2 in acetic acid 0.15 M
(0.125 mL, 2 mg/mL) to the aqueous solution of CHI (1 g, 2.83
wt.% in acetic acid 0.15 M; pH 4.5). The subsequent addition of
urea and urease was accomplished as described above. The
resulting translucent liquid mixture was loaded into an insulin
syringe (1 mL) and aged for gelation (24 hours at 37uC up to reach
a pH of ca. 7.0).
Hydrogels containing CPS either without or with rhBMP-2
were prepared following the procedure described above for CHI
and rhBMP2-CHI hydrogels, respectively, except for the addition
of calcium phosphate to the urea solution (e.g. 0.125 mL, urea 2
M, Ca5(PO4)3OH 0.03 M, HCl 0.3 M; pH 3.0). The resulting
translucent liquid mixture was loaded into an insulin syringe
(1 mL) and aged for gelation (24 hours at 37uC up to reach a pH
of ca. 7.0). All the solutions were previously sterilized by filtration
(0.22 mm) and after the freeze-drying step they were handled in
sterile conditions.
3.2. ISISA processing of hydrogels. Freshly gelled hydro-
gels (CHI, CPS-CHI, rhBMP2-CHI, and rhBMP2-CPS-CHI
hydrogels) were unidirectionally frozen by dipping the insulin
syringes (at a constant rate of 2.7 mm/min) into a liquid nitrogen
bath at 77 K. The frozen samples were freeze-dried using a
ThermoSavant Micromodulyo freeze-drier. The process preserved
the homogeneous distribution of every component throughout the
entire volume of the resulting monolith. The resulting CHI, CPS-
CHI, rhBMP2-CHI, and rhBMP2-CPS-CHI monoliths kept both
the shape and the size of the insulin syringes (ca. 63 mm in height
and 4.5 mm in diameter). The bottom part of the monolith was
always disregarded because of structural heterogeneities [27]. For
the in vitro and in vivo assays monoliths were cryo-fractured (i.e.
prior the freeze-drying step) into scaffolds of 2.5 mm in height and
4.5 mm in diameter. The rhBMP-2 content in rhBMP2-CHI, and
rhBMP2-CPS-CHI scaffolds was ca. 8 mg per scaffold.
4. Samples characterization
Sample morphologies were investigated by scanning electron
microscopy (SEM, Zeiss DSM-950 instrument). The nature of
CPS was studied by transmission electron microscopy (TEM, 200-
KeV JEOL 2000 FXII microscope) as described elsewhere [30].
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Swelling experiments were carried out at 20uC by immersing the
scaffolds in an excess amount of deionized water. The swelling
ratio was calculated as (W22W1)/(W1) %, where W1 and W2 were
the weight of the polymer before and after swelling, respectively.
Mechanical properties of the monoliths were evaluated by
measuring tensile strength versus elongation. For this purpose, dry
cylindrical monoliths of 20 mm in height (obtained by cryo-
fracture, as described above) were gently pressed to obtain
rectangular parallelepipeds of 20 mm in height, 4.6 mm in width
and 200 mm thick. The strain rate was set to 1 mm/min. All
experiments were conducted by triplicate.
5. In vitro assays
5.1. Cell line. Cellular assays were performed using C2C12
cell line (pre-myoblast, mouse, CRL 1772) obtained from the
American Type Culture Collection (Manassas, Virginia). Routine
passaging of the cell line was performed on flasks with Dulbecco’s
modified Eagle’s medium high in glucose, containing 10% fetal
bovine serum plus antibiotics (100 U/mL penicillin and 100 mg/
mL streptomycin sulfate) and maintained in an atmosphere with
5% CO2 at 37uC.
5.2. Experimental design. Scaffolds (4.5 mm in diameter
and 2.5 mm in height) were placed into a 48-well plate and seeded
by triplicate with 10 mL of complete medium containing 26105
trypsinized cells per scaffold dropping-wise directly onto them.
Plates were incubated at 37uC in a humidified 5% CO2
atmosphere for 45 min to allow cells be attached on the scaffolds.
Afterwards, 400 mL of pre-warmed complete culture medium was
carefully added, and the plate was maintained at 37uC in a
humidified 5% CO2 atmosphere. Before any measurement and to
avoid any contamination eventually coming from cells adhered
onto the plastic surface of the well, every scaffold was transferred
to a new well and fresh complete culture medium was added.
Cultures were performed over three time points (24, 72 and
120 hours). Non-seeded scaffolds (i.e. without cells) placed in the
same plate were used as blanks.
5.3. Cell proliferation and viability assay. Alamar Blue
assay (Invitrogen) was used to test cell proliferation at each time
point, following manufacturer instructions. For this purpose,
Alamar Blue reagent was added to culture medium (40 ml of
reagent in 400 ml of medium). After the incubation period (37uC,
90 minutes), the medium was transferred to new wells and the
fluorescence emitted at 590 nm - using lex = 530 nm - was
recorded after subtraction of blank readouts (Biotek FL-600). Final
data were referred to those obtained at 24 hours in order to
provide the relative growth after this time point.
Cell viability was also tested at every time point using the calcein
AM assay (Molecular Probes, Eugene, Oregon, USA) and
following manufacturer instructions. Briefly, cell culture medium
was replaced with 400 mL of PBS-calcein AM (1 mg/mL). Cells
were then incubated over 15 minutes at 37uC. Fluorescent images
were obtained in an Olympus BX51 microscope (Olympus).
5.4. rhBMP-2 activity test. The protein activity was
evaluated by the ability of BMP-2 to induce alkaline phosphatase
in C2C12 cells. Briefly, rhBMP2-CHI and rhBMP2-CPS-CHI
scaffolds were dissolved in 100 mL of 50 mM acetic acid at 37uC
over 1 hour. Then 104 C2C12 cells were seeded in a 48-well plate
using 400 mL of culture medium and 30 mL of every scaffold
solution per well. Considering that the average rhBMP-2 content
per scaffold was 8 mg, 30 mL of solution contained approximately
2.5 mg of protein. Thus, this was the amount of rhBMP-2 used as
positive control, which was also dissolved in acetic acid 50 mM.
The solution of CHI scaffold without protein was used as the
negative control. Cells were incubated for 4 days, then washed
with 200 mL of PBS and finally treated with 100 mL of lysis buffer
(50 mM Tris pH 6.8, 0.1% Triton X-100, 2 mM MgCl2) per well.
After three freeze/thaw cycles, 10 mL of samples were assayed for
alkaline phosphatase activity in 96-well plates, using p-nitrophenyl
phosphate in 2-amino-2-methyl-1-propanol buffer as the substrate
and a total volume of 100 mL. After 10 min at 37uC, the reaction
was stopped with 100 mL of 0.5 M NaOH and the absorbance at
405 nm was measured in a Microplate Reader (Biotek FL-600).
5.5. rhBMP-2 release assays. The protein release from
rhBMP2-CHI and rhBMP2-CPS-CHI scaffolds were analyzed at
eight different time points (0.5, 1, 2, 3, 4, 5, 120, 216 hours) using
specific sandwich ELISA assay (Peprotech, UK) and following
manufacturer instructions. Briefly, a 96-well microplate was
precoated with a rabbit anti-BMP-2 antibody overnight and
blocked over 1 hour with 1% BSA in PBS 1X pH 7.4. Afterwards,
100 mL of culture medium was placed into the microplate and
incubated over 2 hours. Then, biotinylated rabbit anti-BMP-2
antibody was added and incubated over an additional hour. After
that, an Avidin-HRP conjugated was added to the microplate and
incubated over 30 minutes. Finally, ABTS (Sigma) was added and
the absorbance at 405 nm was measured using a Biotek FL-600
microplate reader. All the process was carried out at room
temperature using the absorbance of a culture medium non-
exposed to scaffolds as blank readout. Data obtained were
converted to ng/mL by interpolation on standard curve. Total
rhBMP-2 content was determined multiplying by culture medium
total volume (400 mL).
6. In vivo assays
6.1. Surgery. The in vivo studies were performed in New
Zealand male rabbits of ca. 3 kg in weight. Ten rabbits were used
with different replicates for each sub-group of implant (empty
control, n = 3; CHI, n = 3; rhBMP2-CHI, n = 4; CPS-CHI, n = 4;
rhBMP2-CPS-CHI, n = 6). The rabbits were anesthetized by
intramuscular injection with 2% Rompun (1 mL/10 kg, Bayer)
and Imalgene 1000 (ketamine 20 mg/kg, Merial) making all efforts
to minimize animal suffering. The surgical field (tibiae maesetae of
both legs) was shaved and disinfected. Defects of 4 mm in
diameter were drilled and the scaffolds were implanted. Empty
tibia defects were used as control. The rabbits were placed in
individual cages with food and drink fully available. After a period
of 3 weeks of implantation, the experimental subjects were
sacrificed and samples were collected in formalin for further
analysis.
6.2. Micro-Computed Tomography. Samples were imaged
with an X-ray tube voltage of 50 kV and a current of 200 mA. The
scanning angular rotation was 180u, the angular increment 0.40u,
and the voxel resolution 50 mm. Data sets were reconstructed and
segmented into binary images (8-bit BMP images) for the
subsequent image processing reconstructions using MicroView
ABA 2.2 software (GE Healthcare).
6.3. Histology and histomorphometry. Formalin-fixed
samples were decalcified with 10% and 5% nitric acid over 3
and 2 days, respectively. Afterwards, samples were embedded in
paraffin and the resulting paraffin blocks were cut in 4-mm-thick
slides. The slides were subjected to hematoxylin/eosin and
Masson’s trichrome staining protocols and observed with an
Olympus BX51 microscope. Histomorphometry was carried out
on the slides stained with Masson’s trichrome by measuring newly
formed bone with the CellD software from Olympus. All the
histological processing was performed by Dominion Pharmakine
services.
Chitosan Scaffolds with CPS and rhBMP-2
PLOS ONE | www.plosone.org 3 February 2014 | Volume 9 | Issue 2 | e87149
7. Statistics
Every experiment was performed by triplicate. Data were
expressed as means 6 standard deviation (SD). ANOVA analysis
was performed using SPSS software (SPSS Inc.) to compare
mechanical properties values between different types of scaffolds.
Furthermore, ANOVA was also used in proliferation assays –
carried out to compare cell proliferation rates between scaffolds –
and histomorphometric studies, using Bonferroni post-test to
compare the different scaffolds with the control (empty defect).
Statistical differences were considered significant when P,0.05.
Non-linear regression fitting for rhBMP-2 release assays was
performed with Graph Pad Prism software.
Results and Discussion
Our first interest was to study the morphology of the scaffolds
resulting after the application of the ISISA process to the different
hydrogels. ISISA is just an ice templating process so that upon
freezing, the ice formation (hexagonal form) causes the hydrogel
network (originally occupying the entire hydrogel volume) become
segregated and concentrated between adjacent ice crystals. Freeze-
drying resulted in the formation of structures consisting of
micrometer-sized pores corresponding to the empty areas where
ice crystals originally resided. Thus, ISISA is just like any other
freeze-casting process. The only difference is that freezing is
carried out by immersion of the samples into a cryogenic liquid
(e.g. liquid nitrogen) at a constant dipping rate. This controlled-
immersion process is critical to obtain a homogeneous macro-
porous structure throughout the entire monolith except at the zone
of the probe that first comes into contact with the liquid nitrogen.
In this area the material is dense because the temperature is so low
that amorphous rather than crystalline ice is formed (i.e., water
can supercool when either a solution or hydrogel is submitted to
2196uC because of the presence of solutes) and matter segregation
does not occur. After this first contact, an ice front appears
running upward the non-immersed portion of the probe, the
temperature of which – always above 2196uC – will depend on
the ice front height above the liquid nitrogen level; i.e. the higher
the location of the ice front, the higher its temperature. As
mentioned above, macroporosity corresponds to the empty areas
where ice crystals originally resided so that the dimensions of the
pores are ultimately governed by the dipping rate; i.e. large pores
are obtained at slow dipping rates because of the favoured growth
of ice crystals when the ice front is far from the immersion level. In
our case, we always used an immersion rate of 2.7 mm/min. It is
worth mentioning that we always disregarded the dense portion of
the monolith (e.g. first 3–4 mm of the bottom part of the monolith)
so that the cross-section images shown in figure 1 just revealed the
macroporous structure of CHI, CPS-CHI, rhBMP2-CHI, and
rhBMP2-CPS-CHI scaffolds. SEM micrographs revealed no
remarkable differences between them as correspond to scaffolds
with a common main component (e.g. CHI; see Figure 1). TEM
micrograph allowed determining the major presence of CPS in
form of ACP, that is, as ‘‘Posner clusters’’ of approximately 1.0 nm
in diameter, which aggregate randomly forming large spherical
particles of 20–300 nm with tightly bound water residing within
the interstices (see inset in Figure 1) [30]. The swelling capability in
phosphate buffer (PBS, 0.1 M; pH 7.4) decreased from CHI to
rhBMP2-CHI to rhBMP2-CPS-CHI down to CPS-CHI (Table 1).
The presence of CPS and rhBMP-2 also played a role in the
mechanical properties of the scaffolds (Figure 2, Table 1). For
instance, the elongation at break-point of CPS-CHI exhibited a
significant increase as compared to that of its respective
counterpart (e.g. CHI). A similar trend was observed for
rhBMP2-CPS-CHI and rhBMP2-CHI, with a significant increase
of the elongation at break-point in the scaffolds containing CPS.
Meanwhile, the presence of rhBMP-2 contributed to the elastic
character of the scaffolds with a significant decrease of the Young
Modulus as compared to their respective counterparts. Interest-
ingly, the elongation at break-point also increased in the scaffolds
containing rhBMP-2 (e.g. 13.6% for rhBMP2-CHI versus 10.0%
for CHI, and 21.4% for rhBMP2-CPS-CHI versus 18.0% for
CPS-CHI). The improvement of the elastic properties of samples
containing rhBMP-2 made easier their handling during surgery. It
is worth noting that, from a practical point of view, this was by no
means a trivial issue. This is in agreement with the behavior
described in previous works for incorporation of charged species in
polyelectrolyte hydrogels [32]. Thus, opposite charges results in
attractive forces so that charged species ultimately work as cross-
linkers – with the subsequent increase of the Young modulus –
while when both the polyelectrolyte and the incorporated species
have similar charges, the additive works as a plasticizer and the
Young modulus decreases. This is actually our case, considering
that CHI is a polycation and the rhBMP-2 charge at the pH where
the hydrogel is formed (ca. 7.0) is slightly positive.
At this stage, we were interested in studying whether the
immobilized rhBMP-2 remained active in both rhBMP2-CHI and
rhBMP2-CPS-CHI scaffolds. For this purpose, the scaffolds were
dissolved in acetic acid and the osteoinductive activity of rhBMP-2
was evaluated in the resulting solution. CHI scaffolds similarly
dissolved were used as the negative control and an equivalent
amount of pristine rhBMP-2 was used as the positive control.
Figure 3A shows that the activity of rhBMP-2 immobilized in CHI
remained basically intact as compared to pristine rhBMP-2
whereas the activity of that immobilized in CHI besides CPS
experienced a decrease of nearly 50%. Taking into account that
the scaffold’s manufacturing process was identical in both cases,
and in order to explain these results, we consider the fact that the
acetic acid treatment was not capable to fully dissolve the CPS of
Figure 1. SEM micrographs. Images show the macroporous
structure of CHI (A), CPS-CHI (B), rhBMP2-CHI (C), and rhBMP2-CPS-
CHI (D) scaffolds. Bars are 50 mm. rhBMP2-CHI (C), and rhBMP2-CPS-CHI
(D) scaffolds. Bars are 50 mm. Inset shows CPS in form of ACP in both
CPS-CHI and rhBMP2-CPS-CHI scaffolds. Bar is 30 nm.
doi:10.1371/journal.pone.0087149.g001
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samples. It is worth noting that chromatographic columns
composed of CPS (e.g. hydroxyapatite) are widely used for
BMP-2 separation purposes due to the ability of CPS to adsorb
BMP-2 protein [33]. Also we previously reported that rhBMP-2 is
adsorbed by ceramic scaffolds [12]. Therefore, one could ascribe
this data to an eventual adsorption of rhBMP-2 on non-dissolved
CPS. To confirm this hypothesis, we doubled the amount of acetic
acid added to dissolve the scaffold (200 mL) as well as the
incubation time (2 h). After performing the alkaline phosphatase
assay we observed that now all the rhBMP-2 immobilized in the
rhBMP2-CPS-CHI scaffold showed nearly the same activity than
rhBMP2-CHI scaffold and the positive control (Figure 3A). These
results indicate that all the immobilized protein remained active
after the scaffold manufacturing.
To deepen on it we were interested in studying the release of the
immobilized rhBMP-2 from both rhBMP2-CHI and rhBMP2-
CPS-CHI scaffolds. Figures 3B and 3C shows the release profiles
found for these scaffolds. The concentration of released rhBMP-2
was determined using a sandwich ELISA kit. Raw data were
initially adjusted to a first order release kinetic. Nevertheless, due
to the rhBMP-2 burst liberation – nearly 50% of total amount – at
very short times the initial fit was not good (see in Figure 3B the
values obtained at t = 0, where data are fitted to a one phase
exponential release without the restriction of Y = 0 at t = 0). Thus,
we analysed the data subtracting to all of them the amount of
protein released at t = 0 obtained from the previous fit. We called
them transformed data which fitted then quite acceptably to a
standard first order release kinetic (Fig. 3C). Comparison of fitted
parameters was carried out using the extra sum-of-squares F test.
The profile shapes did not differ apparently between both
scaffolds fitting to a first order release kinetic but the total amount
of rhBMP-2 released from rhBMP2-CHI scaffolds was nearly
1.5-fold that released from rhBMP2-CPS-CHI scaffolds
(Figure 3B). Also the rate constant (K) obtained from the fit after
transforming the data differed between both scaffolds (P,0.01,
Table 2, Figure 3C), indicating that there are different release
kinetic curves for each data set and consequently a slower release
from the rhBMP2-CPS-CHI. In both cases, the amount of
rhBMP-2 released was below the amount of protein originally
immobilized (8 mg). This result may be explained taking into
consideration the behavior of BMP-2 immobilized in CHI. It is
known that CHI swells in contact to solution (PBS or culture
medium) [34]. At first, a burst liberation effect is observed and
then this swelling facilitates BMP-2 diffusion to the solution.
However at seven days only the 15–20% is released to the media
[34]. Since there is neither acidic nor lysozime degradation in the
release assay the scaffold remains almost intact in the culture
medium. Thus a remarkable percentage of protein would be still
immobilized in it. Finally, the differences in total released rhBMP-
2 and release kinetics between these scaffolds could be due to the
capability of CPS to adsorb rhBMP2 so that part of the protein
would be retained – and hence, not released – within the scaffolds
structure.
We next studied cell cultures on scaffolds of 4.5 mm in diameter
and ca. 2.5 mm in height that were obtained by simple cryo-
fracture of the original monoliths obtained from ISISA. Cultured
cells were stained with calcein that labels live cells with bright-
green fluorescence. This assay, performed on rhBMP2-CHI and
rhBMP2-CPS-CHI scaffolds, was extremely useful to observe (1)
the existence of cells attached to the scaffolds (2) how cells
morphology evolved during the culture – e.g. from well-rounded
into fibroblastic-type – within the following days (Figure 4A). After
this first qualitatively assessment, the Alamar Blue assay was
performed to quantify cell proliferation (Figure 4B). Cells
proliferate on CHI, rhBMP2-CHI and CPS-CHI scaffolds over
the first three days. Cell proliferation was slightly higher on
rhBMP2-CPS-CHI scaffolds at this time-point and further
increased – with a significant statistical difference (P,0.05) – over
the following two days (e.g. after 5 days). Neither CPS-CHI nor
rhBMP2-CHI scaffolds exhibited this proliferation trend. In these
two cases, proliferation figures were just maintained after three
days of culture whereas in CHI scaffolds experienced a slight
decrease. Thus, data suggest a synergistic effect of substrate
properties – CPS incorporation and growth factor activity – on cell
proliferation rates.
Figure 2. Mechanical characterization. Plots representing the
tensile strength versus strain for CHI (—), CPS-CHI (– –), rhBMP2-CHI
(???), and rhBMP2-CPS-CHI (–??–) scaffolds.
doi:10.1371/journal.pone.0087149.g002
Table 1. Rheological properties (Young modulus, tensile strength, and elongation at rupture) and swelling ratio of CHI, CPS-CHI,
rhBMP2-CHI, and rhBMP2-CPS-CHI scaffolds.
Scaffold Young modulus (GPa) Tensile Strength (MPa) Strain (%) Swelling ratio (%)
CHI 0.1260.02 4.960.1 10.061.0c 1560
CPS-CHI 0.1260.01 5.560.8 18.060.8c 902
rhBMP2-CHI 0.0760.02a 4.860.5 13.660.7c 1250
rhBMP2-CPS-CHI 0.0560.03a 3.360.9b 21.460.9c 1145
Data are presented as means 6 SD.
aSignificant differences (P,0.05) compared to the scaffolds without rhBMP-2.
bSignificant differences (P,0.05) compared to the rest of scaffolds.
cSignificant differences (P,0.05) between all groups.
doi:10.1371/journal.pone.0087149.t001
Chitosan Scaffolds with CPS and rhBMP-2
PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e87149
Then we proceeded to evaluate the in vivo osteoinductive
response of the scaffolds. For this purpose and as described in
experimental part, 4 mm-in-diameter defects were created in
rabbit tibias. The formation of bone was studied by allocating
every single scaffold in its respective defect over three weeks, using
an empty defect – without any scaffold – as control. The scaffolds
were all of identical size and weight (e.g. 4 mm in diameter,
2.5 mm in height), so that they fitted well into the defects. After
three weeks of implantation, microCT and histological studies
were performed. Figure 5A shows the surgery process and the tibia
gross morphology after euthanasia (B,C). The defects filled with
rhBMP2-CPS-CHI scaffolds exhibited the formation of a major
fraction of dense bone-resembling new tissue at the periostium
whereas only a minor fraction of soft tissue was observed in the
defects filled with CPS-CHI scaffolds. MicroCT analysis
(Figure 5D and S1) confirmed the formation of trabecular bone
in the former case, but neither the latter nor the defects filled with
CHI or CPS-CHI scaffolds followed this trend. Surprisingly,
rhBMP2-CHI apparently shows no more new bone formation
compared to CHI implanted samples, suggesting a role of CPS in
Figure 3. Protein activity and release. A) Graphic shows alkaline phosphatase activity induced in C2C12 cell line. This activity is induced by the
active rhBMP-2 which was released from CHI scaffolds after dissolving them in 100 mL of acetic acid 50 mM for 1 hour (black columns) or 200 mL for
2 hours (white columns). B) Total rhBMP-2 detected in culture media in a time course using ELISA assay. C) rhBMP-2 release kinetic using transformed
data. All data are adjusted to a first order kinetic.
doi:10.1371/journal.pone.0087149.g003
Table 2. Release kinetics parameters for rhBMP2-CHI and
rhBMP2-CPS-CHI scaffolds using Y= Ymax*(1-exp-kt) after
transforming raw data.
Scaffold Ymax K (h
21) t1/2 R
2
rhBMP2-CHI 0.5760.05** 0.1660.04** 4.22 0.76
rhBMP2-CPS-CHI 0.2260.04 0.0960.07 8.01 0.61
K = rate constant expressed in hours21.
**P,0.01.
doi:10.1371/journal.pone.0087149.t002
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rhBMP-2 induced bone formation. Being a critical feature for
bone formation the proper release of BMP-2 from the scaffold
[16,17], it seems that rhBMP-2-CHI scaffold do not provide an
effective delivery frame of included rhBMP-2 in order to allow
bone formation.
Histological analysis was carried out using hematoxylin/eosin
and Masson’s trichrome staining. Hematoxylin/eosin images in
figure 6 show the formation of collagen-rich connective tissue in
every case, both in the empty defect as well as in the defects filled
with the different scaffolds. Tissue formation in the empty defect
mainly occurred at the intramedular space. Bone healing process
has been previously explained in this work [7]. Therefore, this
feature was not surprising given the intrinsic capacity of bone for
self-repair and/or self-regenerate in response to a fracture when
this is below a certain critical size. In fact similar bone formation is
described in clinically performed corticotomies and distraction
osteogenesis surgeries [35]. Actually, in all tested cases newly
formed woven bone was observed, because of native bone
regeneration process.
With regard to the implanted scaffolds, the histological study
(Figure 6) revealed that none scaffold was degraded after three
weeks of implantation and they remained in the defect area. In
every case, the first obvious observation was the formation of a
fibrous capsule at the implant-tissue interface, the thickness of
which around the different scaffolds did not show noticeable
differences (Figure 6). Fibrous capsule formation is a well-
established reaction to implanted biomaterials and is recognized
as the end stage of the foreign body reaction [36]. Neither the
scaffolds pores nor the inner interstice between the scaffolds and
the fibrous capsule exhibited a remarkable formation of new tissue.
Actually, new tissue was only observed around the scaffolds.
Particularly noticeable was the formation of tissue in rhBMP2-
CPS-CHI scaffold, the morphological features of which resembled
those of trabecular bone (Figure 6). In this case, we used the
Masson’s trichrome stain, the broad use of which in bone tissue
studies comes from its specific capability to stain collagen, hence
allowing better contrast between newly formed tissues as
compared to hematoxylin/eosin stains. Interestingly, the presence
Figure 4. Viability and proliferation assays. A) Calcein assay: Green fluorescence corresponds to calcein vital staining at day 1 (D1), day 3 (D3)
and day 5 (D5). Images show a representative experiment on rhBMP2-CPS-CHI scaffolds; B) Alamar Blue assay: Graph shows a time course quantitative
measurement of cell viability for the four scaffolds (CHI, rhBMP2-CHI, CPS-CHI, rhBMP2-CPS-CHI). Relative units are referred to fluorescence units
observed at day 1 in order to remark different cell growth between different scaffolds. *P,0.05 comparing with the other scaffolds at the same time
point.
doi:10.1371/journal.pone.0087149.g004
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of chondral zones adjacent to woven bone revealed that
endochondral ossification – typically observed in naturally-
occurring bone healing processes – also played a role in the
rhBMP2-induced process of bone regeneration described in this
work. Note that histology revealed once again no additional bone
formation in rhBMP-2-CHI samples.
We decided to evaluate the capability of bone regeneration
eventually induced by the presence of the scaffolds by considering
the amount of new tissue that was formed in every case. For this
purpose, we applied histomorphometric analysis to the slides
stained with Masson’s trichrome (Figure 7). The statistical analysis
showed similar newly-formed bone amount for empty controls and
CHI, CPS-CHI and rhBMP2-CHI scaffolds. Nevertheless,
rhBMP2-CPS-CHI scaffolds formed significantly higher amount
of new bone (P,0.01). This result revealed that the efficacy in
bone regeneration of the scaffolds studied in this work was superior
when mineralization agents (e.g. CPS) and bone morphogenetic
proteins (e.g. rhBMP-2) act in a combined fashion rather than
separately.
Conclusions
We have prepared CHI scaffolds containing both CPS and
rhBMP2. We have observed that rhBMP2 was not only released in
a controlled fashion from CHI scaffolds but also preserved its
osteoinductive character after release. Interestingly, we found that
this multicomponent scaffold exhibited a superior efficacy in bone
regeneration than the scaffolds containing only one of the
components, either CPS or rhBMP2, separately. This enhanced
performance in both osteoconductive and osteoinductive terms
opens the path to the future clinical application of these materials
in dental surgery and, more specifically, in maxillary sinus
Figure 5. Surgery (A), gross morphology after euthanasia (B, C) and microCT analysis of samples (D). Surgery images (A) show scaffold
implantation process. After euthanasia gross morphology images were obtained at different angles (B,C) (Dotted circle indicates defect location).
Defect area is still observed in CPS-CHI implanted tibias (B), while in rhBMP2-CPS-CHI implanted tibias high amount of newly-formed hard tissue,
apparently bone, appeared vertically from the defect (C). MicroCT study (D) confirms trabecular bone formation in rhBMP2-CPS-CHI implanted tibias,
while it seems no scaffold-resorption in any case. Neither seems a robust new bone formation in the rest of implanted scaffolds compared to empty
controls.
doi:10.1371/journal.pone.0087149.g005
Figure 6. Histology. A) Hematoxylin-eosin staining. A1) Empty control, A2) CHI scaffold, A3) rhBMP2-CHI scaffold, A4) CPS-CHI scaffold, A5) rhBMP2-
CPS-CHI scaffold. Different lines are limiting newly formed woven bone (WB, ???) with resembles trabecular bone structure (intramedular as well as
extramedullar), cortical bone (CB, —) and fibrous tissue (F, – – –). All images were taken at 26. B) Masson’s Trichrome staining. B1) CPS-CHI scaffold. A
little amount of bone is formed, and a connective tissue (red arrow) is observed around the matrix, B2-5) rhBMP2-CPS-CHI scaffold. Great amount of
new bone is formed, most of it extramedullar trabecular bone (WB). Detailed image (B3) shows a dotted line limiting native cortical bone (CB, —) and
newly formed woven bone (WB). Chondral areas (CD) appear in the limits of newly formed tissue (B4, B5) here limited with woven bone indicating
new bone formation via osteochondral ossification. Images B1, B2 and B5 were taken at 56. Images B3 and B4 were taken at 106. All histological
slides were from the closest zone to the center of the defect as possible.
doi:10.1371/journal.pone.0087149.g006
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augmentation procedure. In this procedure, large area of the
maxillary sinus are lifted and replaced with bone, which serves to
support future implant placement. It is worth noting that the filling
material most used nowadays is porous resorbable hydroxyapatite,
which is osteoconductive but not osteoinductive as the rhBMP2-
CPS-CHI scaffolds described in this work.
Supporting Information
Figure S1 MicroCT images of rhBMP-2-CPS-CHI scaf-
folds implanted in rabbit tibias. Trabecular bone formation
is observed in all cases.
(TIF)
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